Emergent BioSolutions Inc. (EBS) Free Cash Flow
Emergent BioSolutions Inc. (EBS) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-12-31 | -$21.63M |
| 2017-12-31 | $75.70M |
| 2018-12-31 | -$27.70M |
| 2019-12-31 | $101.10M |
| 2020-12-31 | $395.00M |
| 2021-12-31 | $96.10M |
| 2022-12-31 | -$149.90M |
| 2023-12-31 | -$257.90M |
| 2024-12-31 | $35.80M |
| 2025-12-31 | $156.80M |
How EBS compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| ARRY | Array Technologies Inc. | $79.81M |
| AKBA | Akebia Therapeutics Inc. | $67.70M |
| TGTX | TG Therapeutics Inc. | -$24.99M |
| ACRS | Aclaris Therapeutics Inc. | -$47.22M |
| ALT | Altimmune Inc. | -$67.55M |
These are five companies in the same sector as EBS with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Emergent BioSolutions Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("EBS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | EBS | $5.91 | -0.51% | 1.24M |
| 3 | ||||
| 4 | ||||
| 5 |